-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Adient, Raises Price Target to $20

Benzinga·01/29/2025 14:38:32
Listen to the news
UBS analyst Joseph Spak maintains Adient (NYSE:ADNT) with a Neutral and raises the price target from $19 to $20.